Hercules Tech backs biopharmaceutical with $30m

 The biotechnology finance firm has provided a three-tranche $45m term loan to drug developer Anacor Pharmaceuticals.     

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.